The Salmonella effector SspH2 disrupts F-actin cytoskeletal organization to inhibit macrophage migration
This study demonstrates that the *Salmonella* effector SspH2 utilizes its E3 ubiquitin ligase activity to disrupt vinculin-associated F-actin cytoskeletal structures, thereby inhibiting macrophage migration and facilitating immune evasion.
Original paper dedicated to the public domain under CC0 1.0 (https://creativecommons.org/publicdomain/zero/1.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Inside the human body, a constant, silent war is waged between invading bacteria and the immune system's first responders: macrophages. These specialized white blood cells act as mobile sentinels, patrolling tissues and rushing toward sites of infection to engulf and destroy pathogens. For a bacterium to survive and spread, it must not only resist being eaten but also stop these immune cells from arriving. One such invader, Salmonella enterica serovar Typhimurium, a common cause of foodborne illness, has evolved a sophisticated toolkit to disable its host's defenses. Among its arsenal is a molecular weapon called SspH2, a protein injected directly into the immune cell that seems to paralyze the cell's ability to move. While scientists knew this protein could stop cells from migrating, the exact mechanism by which it achieved this feat remained a mystery, leaving a gap in our understanding of how bacteria hijack the very machinery that keeps us healthy.
A team of researchers set out to solve this puzzle by observing how Salmonella and its SspH2 protein interact with macrophages in the laboratory. They began by infecting mouse immune cells with the bacteria and watching them in real time. They found that when the bacteria were present, the cells lost their ability to crawl across a surface, effectively freezing them in place. To prove that SspH2 was the specific culprit, the scientists engineered cells to produce only this single protein, without any other bacterial parts. The result was immediate and striking: the mere presence of SspH2 was enough to halt the cells' movement. The researchers then looked closer at the internal structure of these immobilized cells. They discovered that the cells' internal skeleton, made of long, stringy proteins called actin, had been dismantled. In healthy, moving cells, these actin strings form organized, ring-like structures that act as anchors, allowing the cell to grip the surface and pull itself forward. In cells exposed to SspH2, these rings vanished, and the total amount of actin dropped significantly, leaving the cell unable to generate the force needed to move.
The study went further to determine how the bacteria achieved this destruction. The SspH2 protein is known to function as an enzyme that tags other proteins for disposal, a process essential for its activity. When the researchers created a version of SspH2 that had this tagging ability switched off, the protein became harmless; the cells continued to move normally, and their internal skeletons remained intact. This confirmed that the protein's enzymatic power was the key to breaking the cell's mobility. The team then traced the target of this enzymatic attack to a specific host protein called vinculin. Vinculin acts as a critical connector, linking the internal actin skeleton to the cell's outer surface. When the researchers removed vinculin from the cells, the cells stopped moving, just as they did when SspH2 was present. Crucially, when they added SspH2 to these vinculin-free cells, the protein could no longer slow them down any further. This suggested that SspH2 relies on the presence of vinculin to do its damage, likely by disrupting the complex structures that vinculin helps build.
The findings reveal a precise strategy used by Salmonella to evade the immune system. By injecting SspH2 into macrophages, the bacteria trigger a chain reaction that breaks down the cell's internal scaffolding. This process depends on the cell's own connector proteins, specifically vinculin, which the bacteria seem to exploit to dismantle the very structures required for movement. The research shows that without these actin-rich rings, the immune cells cannot migrate to the site of infection, allowing the bacteria to hide and persist. This work identifies a new pathway by which a common pathogen disables the immune response, not by killing the cell, but by quietly disabling its ability to move. It highlights how bacteria can co-opt the host's own molecular machinery, turning a vital defense mechanism into a point of failure, ensuring the pathogen's survival within the body.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.